A Mathematical Framework for Estimating Pathogen Transmission Fitness and Inoculum Size Using Data from a Competitive Mixtures Animal Model
暂无分享,去创建一个
James M. McCaw | Angela R. McLean | Nimalan Arinaminpathy | Aeron C. Hurt | Jodie McVernon | N. Arinaminpathy | J. McVernon | A. McLean | J. McCaw | A. Hurt
[1] Christopher T. McCaw,et al. Impact of Emerging Antiviral Drug Resistance on Influenza Containment and Spread: Influence of Subclinical Infection and Strategic Use of a Stockpile Containing One or Two Drugs , 2008, PloS one.
[2] B. Levin,et al. Antiviral Resistance and the Control of Pandemic Influenza , 2007, PLoS medicine.
[3] R. Webster,et al. Oseltamivir–Resistant Pandemic H1N1/2009 Influenza Virus Possesses Lower Transmissibility and Fitness in Ferrets , 2010, PLoS pathogens.
[4] J. van de Kassteele,et al. Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season , 2009, Emerging infectious diseases.
[5] A. Monto,et al. Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. , 2002, Antiviral research.
[6] Marc Lipsitch,et al. Hedging against Antiviral Resistance during the Next Influenza Pandemic Using Small Stockpiles of an Alternative Chemotherapy , 2009, PLoS medicine.
[7] R. Webster,et al. Competitive Fitness of Oseltamivir-Sensitive and -Resistant Highly Pathogenic H5N1 Influenza Viruses in a Ferret Model , 2010, Journal of Virology.
[8] A. Kelso,et al. The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[9] A. McLean,et al. Assessing the Viral Fitness of Oseltamivir-Resistant Influenza Viruses in Ferrets, Using a Competitive-Mixtures Model , 2010, Journal of Virology.
[10] A. Perelson,et al. Kinetics of Influenza A Virus Infection in Humans , 2006, Journal of Virology.
[11] D. Cummings,et al. Strategies for containing an emerging influenza pandemic in Southeast Asia , 2005, Nature.
[12] R. Davey,et al. Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. , 2010, The Journal of antimicrobial chemotherapy.
[13] Gilles Clermont,et al. A Dynamical Model of Human Immune Response to Influenza a Virus Infection , 2006 .
[14] Andreas Handel,et al. Towards a quantitative understanding of the within-host dynamics of influenza A infections , 2010, Journal of The Royal Society Interface.
[15] Tracking the emergence of pandemic Influenza A/H1N1/2009 and its interaction with seasonal influenza viruses in Singapore. , 2010, Annals of the Academy of Medicine, Singapore.
[16] R. May,et al. Infectious disease dynamics: What characterizes a successful invader? , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[17] John Samuel,et al. A simple cellular automaton model for influenza A viral infections. , 2004, Journal of theoretical biology.
[18] David Smith,et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. , 2009, Antiviral research.
[19] Andreas Handel,et al. Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread , 2007, PLoS Comput. Biol..
[20] Lynnette Brammer,et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. , 2009, JAMA.
[21] H. Chu,et al. Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants , 2009, Journal of Virology.